Digital Health Regulation Is Entering a Reform, Not Revolution, Phase
A Digital Health survey suggests people want reform of AI regulation in healthcare, but not a full overhaul. That distinction matters because it points to a public that is cautious about AI, but not eager to freeze innovation. The finding hints that the real policy battle is over calibration: how to keep AI accountable without making it unusable.
The latest signal from the digital health sector is that stakeholders want AI regulation to evolve, but not be torn up and rewritten. That is an important distinction. It suggests the market is not rejecting oversight; it is asking for rules that are clearer, more adaptive, and better aligned with how AI is actually deployed in healthcare.
This makes sense. The current problem is often not the absence of regulation, but the mismatch between static rules and dynamic systems. AI tools change quickly, and healthcare use cases vary widely, so blunt regulation can either leave gaps or create unnecessary friction.
A reform-not-overhaul mindset also reflects a maturing industry. Companies want a framework they can work within, and clinicians want confidence that tools have been validated and monitored. Neither group benefits from uncertainty, whether that uncertainty comes from regulatory ambiguity or from overcorrection.
The broader message is that healthcare AI is entering a more serious phase. Public tolerance exists, but it is conditional on safety, transparency, and practical benefit. Regulators who recognize that balance may be able to support innovation without surrendering oversight.